iZafe Group ABFRA:M02 -5.06%48 PB Ratio is 5.63 as of Jun. 25, 2026, which is 72% above its 10-year median of 3.28. GuruFocus rates FRA:M02 with a GF Score™ of 48/100 and a GF Value™ of €0.04 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 788 Medical Devices & Instruments companies, iZafe Group AB ranks worse than 83.25% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-25), iZafe Group AB's share price is €0.0338. iZafe Group AB's Book Value per Share for the quarter that ended in Mar. 2026 was €0.01. Hence, iZafe Group AB's PB Ratio of today is 5.63.
The historical rank and industry rank for iZafe Group AB's PB Ratio or its related term are showing as below:
FRA:M02'
s PB Ratio Range Over the Past 10 Years
Min: 0.55 Med: 3.28 Max: 23.92
Current: 6.52
During the past 13 years, iZafe Group AB's highest PB Ratio was 23.92. The lowest was 0.55. And the median was 3.28.
FRA:M02's PB Ratio is ranked worse than 83.25% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.045
vs FRA:M02: 6.52
During the past 12 months, iZafe Group AB's average Book Value Per Share Growth Rate was 50.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -49.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -51.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -28.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of iZafe Group AB was 36.00% per year. The lowest was -60.70% per year. And the median was -12.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
iZafe Group AB PB Ratio Related Terms
iZafe Group AB PB Ratio Historical Data
* Premium members only.
The historical data trend for iZafe Group AB's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, iZafe Group AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iZafe Group AB PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iZafe Group AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where iZafe Group AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
iZafe Group AB's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
iZafe Group AB (FRA:M02) has a PB Ratio of 5.63 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on iZafe Group AB and its competitors. This is 72% above median its historical median of 3.28. Over the past decade, iZafe Group AB's PB Ratio has ranged from 0.55 to 23.92. According to the industry distribution chart, iZafe Group AB ranks #656 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 83.2%.
Is iZafe Group AB's PB Ratio too high?
iZafe Group AB's current PB Ratio of 5.63 is 72% above median its 10-year median of 3.28. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 23.92. The Medical Devices & Instruments industry median PB Ratio is 2.05. iZafe Group AB's value of 5.63 is 175.3% above this industry median. Based on the distribution chart, iZafe Group AB ranks #656 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, iZafe Group AB has a GF Score™ of 48/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iZafe Group AB's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, iZafe Group AB ranks #656 out of 788 companies for PB Ratio. This places iZafe Group AB in the lower half of its industry. The industry median PB Ratio is 2.05. iZafe Group AB's value of 5.63 is 175.3% above this benchmark. Historically, iZafe Group AB's own PB Ratio has ranged from 0.55 to 23.92 over the past decade. While the company's 10-year median is 3.28 vs. the industry median of 2.05, iZafe Group AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iZafe Group AB's current PB Ratio of 5.63 is 175.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on iZafe Group AB and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iZafe Group AB's current PB Ratio is 5.63, which is 72% above median its own 10-year median of 3.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iZafe Group AB stock overvalued right now?
Based on GuruFocus' analysis, iZafe Group AB (FRA:M02) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.04, compared to a current price of €0.03 — trading 15.5% below its estimated fair value. The current PB Ratio is 5.63, which is 72% above median its 10-year median of 3.28 and 175.3% above the Medical Devices & Instruments industry median of 2.05. iZafe Group AB's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For iZafe Group AB (FRA:M02), the current PB Ratio is 5.63 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iZafe Group AB (FRA:M02) Overvalued in 2026?
Based on GuruFocus' analysis, iZafe Group AB stock appears to be undervalued.
The current stock price of €0.03 is trading 15.5% below its estimated GF Value™ of €0.04.
GuruFocus considers iZafe Group AB to be Modestly Undervalued.
Key valuation signals for FRA:M02:
PB Ratio: 5.63 (72% above median its 10-year median of 3.28)
GF Value™: €0.04 vs. price of €0.03 (15.5% below fair value)
Industry Position: 175.3% above the Medical Devices & Instruments median (#656 of 788)
No single metric tells the full story. See the FRA:M02 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iZafe Group AB is a Developer of a digital medication dispensing system designed to enhance patient safety and reduce medication errors in home healthcare. The company offers a smart medication robot with automated dispensing and remote monitoring, enabling public and private healthcare providers in Sweden, the Nordics, and international markets, improved treatment adherence and reduced caregiver workload.
48GF Score
Get the complete analysis for FRA:M02
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M02 has been successfully added to your 
